About Walgreens Boots Alliance (NASDAQ:WBA)
Walgreens Boots Alliance, Inc. (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand). In addition, the Company has investments in Guangzhou Pharmaceuticals Corporation and Nanjing Pharmaceutical Company Limited. The Company operates in around 25 countries, which include the wholesale and distribution network with over 340 distribution centers and more than 180,000 pharmacies, health centers and hospitals in 19 countries.
Industry, Sector and Symbol:
- Market Cap: $72.8308 billion
- Outstanding Shares: 1,070,096,000
- 50 Day Moving Avg: $76.37
- 200 Day Moving Avg: $80.09
- 52 Week Range: $66.92 - $89.69
Sales & Book Value:
- Trailing P/E Ratio: 17.19
- Foreward P/E Ratio: 12.42
- P/E Growth: 1.15
- Annual Revenue: $116.7 billion
- Price / Sales: 0.62
- Book Value: $28.60 per share
- Price / Book: 2.38
- Annual Dividend: $1.60
- Dividend Yield: 2.4%
- EBITDA: $7.34 billion
- Net Margins: 3.69%
- Return on Equity: 17.34%
- Return on Assets: 7.26%
- Debt-to-Equity Ratio: 0.46%
- Current Ratio: 1.30%
- Quick Ratio: 0.90%
- Average Volume: 5.91 million shs.
- Beta: 1.25
- Short Ratio: 2.32
Frequently Asked Questions for Walgreens Boots Alliance (NASDAQ:WBA)
What is Walgreens Boots Alliance's stock symbol?
Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."
How often does Walgreens Boots Alliance pay dividends? What is the dividend yield for Walgreens Boots Alliance?
Walgreens Boots Alliance announced a quarterly dividend on Thursday, July 13th. Shareholders of record on Friday, August 18th will be paid a dividend of $0.40 per share on Tuesday, September 12th. This represents a $1.60 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date is Wednesday, August 16th. This is an increase from Walgreens Boots Alliance's previous quarterly dividend of $0.38. View Walgreens Boots Alliance's Dividend History.
How will Walgreens Boots Alliance's stock buyback program work?
Walgreens Boots Alliance announced that its Board of Directors has approved a stock repurchase plan on Friday, June 30th 2017, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 5.9% of its stock through open market purchases. Stock buyback plans are typically a sign that the company's management believes its stock is undervalued.
How were Walgreens Boots Alliance's earnings last quarter?
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) issued its earnings results on Wednesday, July, 6th. The company reported $1.18 EPS for the quarter, beating the Zacks' consensus estimate of $1.14 by $0.04. The firm earned $29.50 billion during the quarter, compared to analysts' expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. Walgreens Boots Alliance's quarterly revenue was up 2.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.02 earnings per share. View Walgreens Boots Alliance's Earnings History.
When will Walgreens Boots Alliance make its next earnings announcement?
Where is Walgreens Boots Alliance's stock going? Where will Walgreens Boots Alliance's stock price be in 2017?
19 equities research analysts have issued 12 month price objectives for Walgreens Boots Alliance's shares. Their forecasts range from $72.00 to $100.00. On average, they expect Walgreens Boots Alliance's stock price to reach $88.81 in the next year. View Analyst Ratings for Walgreens Boots Alliance.
What are analysts saying about Walgreens Boots Alliance stock?
Here are some recent quotes from research analysts about Walgreens Boots Alliance stock:
- 1. According to Zacks Investment Research, "Walgreens faces tough competitive landscapes along with currency fluctuations. Also, slowdown in generic introduction continues to weigh upon the company’s margins. However, over the last year, Walgreens has been trading above the broader industry. The company finally gaining approval from the U.S. Federal Trade Commission (FTC) for the modified deal involving purchase of a number of Rite Aid (RAD) store buoys optimism. Although investors did not show much optimism regarding the company’s purchase of fewer-than-expected stores, we believe the deal’s financial outcome is pretty attractive. Moreover, this modified merger contract is expected to extend Walgreens’ growth strategy and offer additional operational benefits. We are also upbeat about Walgreens’ ‘Next Chapter plan’ through fiscal 2017 focusing on a multi-faceted cost-reduction initiative across the enterprise." (10/17/2017)
- 2. Pivotal Research analysts commented, "We believe that the asset based transaction with Rite Aid is much more beneficial for Walgreens Boots Alliance compared to the amended merger agreement from January 2017. Our quick read thru is that WBA is paying around $2.5 million per store compared to more than $4.1 million under the proposed transaction which would have included the divestiture of up to 1200 stores to Fred’s. Management appears to have a high level of confidence that it understands what is required from an FTC perspective and that the third attempt to consummate a deal with Rite Aid will pass regulatory scrutiny. The newly authorized share buyback program of $5 billion is also a significant positive for investors. The scaled down version transaction with Rite Aid will allow Walgreen to shrink the count at an accelerated rate through FY18. That said, we expect that core earnings will continue to be pressured. Quality of earnings was lacking of 3Q17, with a $0.07-$0.08 per share benefit from a lower than expected tax rate. Additionally, FIFO gross margin was down by 150 bps in the latest quarter on continued reimbursement pressures." (7/2/2017)
- 3. Jefferies Group LLC analysts commented, "We believe that today’s announcement of the proposed divestiture of 865 RAD stores to FRED for $950MM in cash should be sufficient to appease regulatory competition concerns and eliminate concerns about WBA’s ability to close the RAD deal." (12/21/2016)
Are investors shorting Walgreens Boots Alliance?
Walgreens Boots Alliance saw a increase in short interest during the month of September. As of September 29th, there was short interest totalling 21,631,489 shares, an increase of 9.0% from the September 15th total of 19,846,113 shares. Based on an average daily trading volume, of 6,371,016 shares, the days-to-cover ratio is currently 3.4 days. Approximately 2.3% of the company's stock are short sold.
Who are some of Walgreens Boots Alliance's key competitors?
Some companies that are related to Walgreens Boots Alliance include McDonald's Corporation (MCD), Inditex (IDEXY), The Priceline Group (PCLN), Starbucks Corporation (SBUX), CVS Health Corporation (CVS), Costco Wholesale Corporation (COST), Lowe's Companies (LOW), Kering Unspon (PPRUY), TJX Companies, Inc. (The) (TJX), Hennes & Mauritz AB (HNNMY), eBay (EBAY), Wal-Mart de Mexico SAB de CV (WMMVY), Target Corporation (TGT), Compass Group PLC (CMPGY), Yum! Brands (YUM), Ctrip.com International (CTRP), Ross Stores (ROST) and Expedia (EXPE).
Who owns Walgreens Boots Alliance stock?
Walgreens Boots Alliance's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include APG Asset Management N.V. (0.23%), PGGM Investments (0.09%), State Treasurer State of Michigan (0.03%), Alta Capital Management LLC (0.02%), Mutual of America Capital Management LLC (0.02%) and Monarch Capital Management Inc. (0.01%). Company insiders that own Walgreens Boots Alliance stock include Barry Rosenstein, George Rollo Fairweather, Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.
Who sold Walgreens Boots Alliance stock? Who is selling Walgreens Boots Alliance stock?
Walgreens Boots Alliance's stock was sold by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Park National Corp OH, Wendell David Associates Inc., Bridges Investment Counsel Inc., Shikiar Asset Management Inc., Private Asset Management Inc., Monarch Capital Management Inc. and Bath Savings Trust Co. Company insiders that have sold Walgreens Boots Alliance stock in the last year include Kathleen Wilson-Thompson and William C Foote. View Insider Buying and Selling for Walgreens Boots Alliance.
Who bought Walgreens Boots Alliance stock? Who is buying Walgreens Boots Alliance stock?
Walgreens Boots Alliance's stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Oakbrook Investments LLC, Carnick & Kubik Group LLC, Mutual of America Capital Management LLC, Assenagon Asset Management S.A., Hefty Wealth Partners, Rockefeller Financial Services Inc. and Alta Capital Management LLC. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.
How do I buy Walgreens Boots Alliance stock?
Shares of Walgreens Boots Alliance can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Walgreens Boots Alliance's stock price today?
MarketBeat Community Rating for Walgreens Boots Alliance (NASDAQ WBA)MarketBeat's community ratings are surveys of what our community members think about Walgreens Boots Alliance and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Walgreens Boots Alliance stock can currently be purchased for approximately $68.06.
Consensus Ratings for Walgreens Boots Alliance (NASDAQ:WBA) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||6 Hold Ratings, 13 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.68)|
|Consensus Price Target: ||$88.81 (30.49% upside)|Consensus Price Target History for Walgreens Boots Alliance (NASDAQ:WBA)
Analysts' Ratings History for Walgreens Boots Alliance (NASDAQ:WBA)
(Data available from 10/22/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/19/2017||Robert W. Baird||Reiterated Rating||Outperform||$90.00 -> $80.00||N/A|
|10/15/2017||SunTrust Banks, Inc.||Set Price Target||Hold||$72.00||N/A|
|10/12/2017||Needham & Company LLC||Reiterated Rating||Buy||$94.00||N/A|
|10/6/2017||Morgan Stanley||Downgrade||Overweight -> Equal Weight||$95.00 -> $85.00||N/A|
|10/2/2017||Jefferies Group LLC||Reiterated Rating||Buy||$95.00||Low|
|9/27/2017||Raymond James Financial, Inc.||Reiterated Rating||Outperform -> Market Perform||Low|
|9/19/2017||Royal Bank Of Canada||Initiated Coverage||Outperform -> Outperform||$96.00||Medium|
|8/24/2017||Loop Capital||Initiated Coverage||Buy -> Buy||$95.00||Low|
|7/13/2017||Credit Suisse Group||Reiterated Rating||Buy||$97.00||Low|
|7/7/2017||Leerink Swann||Set Price Target||Buy||$90.00 -> $86.00||Low|
|7/3/2017||Citigroup Inc.||Reiterated Rating||Buy||Low|
|7/2/2017||Pivotal Research||Set Price Target||Hold||$85.00||Low|
|6/28/2017||Goldman Sachs Group, Inc. (The)||Reiterated Rating||Neutral||$89.00 -> $77.00||Low|
|4/1/2017||Barclays PLC||Set Price Target||Hold||$79.00||Low|
|3/22/2017||Deutsche Bank AG||Reiterated Rating||Buy||$92.00||Low|
|2/6/2017||Atlantic Securities||Upgrade||Neutral -> Overweight||$95.00||N/A|
|1/31/2017||Evercore ISI||Reiterated Rating||Buy||$93.00||N/A|
|1/31/2017||Wells Fargo & Company||Reiterated Rating||Outperform||N/A|
|8/30/2016||Bank of America Corporation||Reiterated Rating||Buy||$94.00||N/A|
|7/22/2016||Keefe, Bruyette & Woods||Reiterated Rating||Market Perform -> Underperform||N/A|
|7/7/2016||J P Morgan Chase & Co||Reiterated Rating||Buy||N/A|
|7/7/2016||FBR & Co||Lower Price Target||Market Perform||$90.00 -> $85.00||N/A|
|3/1/2016||Mizuho||Upgrade||Neutral -> Buy||$89.00 -> $90.00||N/A|
|10/30/2015||Scotiabank||Boost Price Target||$100.00 -> $101.00||N/A|
|10/29/2015||S&P Equity Research||Reiterated Rating||Buy||$99.00||N/A|
|10/28/2015||Cowen and Company||Reiterated Rating||Buy||$102.00||N/A|
Earnings History for Walgreens Boots Alliance (NASDAQ:WBA)Earnings History by Quarter for Walgreens Boots Alliance (NASDAQ WBA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|10/25/2017|| || || || || || || || |
|6/29/2017||Q3 2017||$1.30||$1.33||$29.72 billion||$30.12 billion||View||N/A|
|4/5/2017||Q2 2017||$1.36||$1.36||$30.17 billion||$29.45 billion||View||Listen|
|1/5/2017||Q117||$1.09||$1.10||$29.37 billion||$28.50 billion||View||Listen|
|10/20/2016||Q416||$0.99||$1.07||$29.06 billion||$28.60 billion||View||Listen|
|7/6/2016||Q316||$1.14||$1.18||$29.93 billion||$29.50 billion||View||N/A|
|4/5/2016||Q216||$1.28||$1.31||$30.72 billion||$30.18 billion||View||N/A|
|1/7/2016||Q116||$0.96||$1.03||$29.24 billion||$29.00 billion||View||N/A|
|10/28/2015||Q415||$0.81||$0.88||$28.45 billion||$28.50 billion||View||Listen|
|7/9/2015||Q315||$0.87||$1.02||$30.28 billion||$28.80 billion||View||N/A|
|4/9/2015||Q215||$0.94||$1.18||$27.27 billion||$26.60 billion||View||N/A|
|12/23/2014||Q115||$0.75||$0.81||$19.43 billion||$19.55 billion||View||N/A|
|9/30/2014||Q414||$0.74||$0.74||$19.02 billion||$19.06 billion||View||N/A|
|6/24/2014||Q314||$0.94||$0.91||$19.33 billion||$19.40 billion||View||N/A|
|3/25/2014||Q214||$0.93||$0.91||$19.61 billion||$19.60 billion||View||N/A|
|12/20/2013||Q1||$0.72||$0.72||$17.98 billion||$18.30 billion||View||Listen|
|10/1/2013||Q413||$0.72||$0.73||$17.95 billion||$17.90 billion||View||N/A|
|6/25/2013||Q3 2013||$0.91||$0.85||$18.44 billion||$18.30 billion||View||N/A|
|3/19/2013||Q2 2013||$0.94||$0.96||$18.72 billion||$18.65 billion||View||N/A|
|12/21/2012||Q1 2013||$0.70||$0.58||$17.50 billion||$17.32 billion||View||N/A|
|9/28/2012||Q412||$0.56||$0.63||$17.16 billion||$17.10 billion||View||N/A|
|12/22/2010||$0.54||$0.62||$17.31 billion||$17.34 billion||View||N/A|
Earnings Estimates for Walgreens Boots Alliance (NASDAQ:WBA)
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Current Dividend Information for Walgreens Boots Alliance (NASDAQ:WBA)
|Most Recent Dividend:||9/12/2017|
|Payout Ratio:||40.30% (Trailing 12 Months of Earnings) |
31.94% (Based on This Year's Estimates)
29.20% (Based on Next Year's Estimates)
Dividend History by Quarter for Walgreens Boots Alliance (NASDAQ WBA)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Walgreens Boots Alliance (NASDAQ:WBA)
Insider Ownership Percentage: 13.50%Insider Trades by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)
Institutional Ownership Percentage: 60.14%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|7/25/2017||William C Foote||Director||Sell||2,736||$79.79||$218,305.44|| |
|5/3/2017||William C Foote||Director||Sell||2,736||$85.89||$234,995.04|| |
|2/7/2017||Ornella Barra||COO||Buy||124,000||$80.93||$10,035,320.00|| |
|2/2/2017||Janice M Babiak||Director||Buy||600||$80.68||$48,408.00|| |
|11/28/2016||Kathleen Wilson-Thompson||EVP||Sell||5,700||$85.05||$484,785.00|| |
|11/4/2016||Stefano Pessina||Insider||Buy||2,000,000||$81.41||$162,820,000.00|| |
|11/2/2016||William C Foote||Director||Sell||2,067||$81.30||$168,047.10|| |
|9/8/2016||Kathleen Wilson-Thompson||EVP||Sell||23,996||$85.00||$2,039,660.00|| |
|7/26/2016||William C Foote||Director||Sell||2,067||$81.35||$168,150.45|| |
|7/14/2016||Kathleen Wilson-Thompson||EVP||Sell||29,695||$83.00||$2,464,685.00|| |
|7/8/2016||Kathleen Wilson-Thompson||EVP||Sell||29,695||$81.03||$2,406,185.85|| |
|6/10/2016||Kathleen Wilson-Thompson||EVP||Sell||29,603||$83.13||$2,460,897.39|| |
|5/16/2016||Barry Rosenstein||Director||Sell||6,000,000||$77.29||$463,740,000.00|| |
|4/21/2016||William C Foote||Director||Sell||2,066||$80.99||$167,325.34|| |
|4/15/2016||George Rollo Fairweather||CFO||Sell||50,000||$81.52||$4,076,000.00|| |
|3/17/2016||Kathleen Wilson-Thompson||EVP||Sell||13,728||$83.01||$1,139,561.28|| |
|2/18/2016||Barry Rosenstein||Director||Sell||1,720,900||$76.96||$132,440,464.00|| |
|1/12/2016||John Anthony Lederer||Director||Buy||10,000||$81.00||$810,000.00|| |
|11/20/2015||Barry Rosenstein||Director||Sell||1,452,470||$82.37||$119,639,953.90|| |
|11/4/2015||William C Foote||Director||Sell||3,500||$88.36||$309,260.00|| |
|11/2/2015||John Anthony Lederer||Director||Buy||10,000||$84.88||$848,800.00|| |
|7/16/2015||William C Foote||Director||Sell||3,500||$94.95||$332,325.00|| |
|4/29/2015||John Anthony Lederer||Director||Buy||10,000||$85.00||$850,000.00|| |
|1/29/2015||Thomas J Sabatino Jr||CAO||Sell||36,477||$73.76||$2,690,543.52|| |
|12/15/2014||Kathleen Wilson-Thompson||SVP||Sell||40,769||$73.75||$3,006,713.75|| |
|11/7/2014||Kermit R Crawford||EVP||Sell||126,441||$66.32||$8,385,567.12|| |
|11/3/2014||Sona Chawla||CMO||Sell||21,200||$65.00||$1,378,000.00|| |
|10/14/2014||Barry Rosenstein||Director||Buy||1,250,000||$61.86||$77,325,000.00|| |
|9/19/2014||Sona Chawla||CMO||Sell||9,443||$63.44||$599,063.92|| |
|8/11/2014||Mia M Scholz||SVP||Sell||81,015||$61.93||$5,017,258.95|| |
|8/7/2014||Gregory D Wasson||CEO||Sell||24,279||$60.06||$1,458,196.74|| |
|4/16/2014||Robert Zimmerman||SVP||Sell||26,201||$66.07||$1,731,100.07|| |
|4/15/2014||Kermit Crawford||Insider||Sell||74,287||$66.01||$4,903,684.87|| |
|1/24/2014||Graham Atkinson||SVP||Sell||24,304||$58.05||$1,410,847.20|| |
|1/16/2014||Robert Zimmerman||SVP||Sell||10,426||$60.00||$625,560.00|| |
|1/13/2014||Timothy Theriault||SVP||Sell||64,815||$60.50||$3,921,307.50|| |
|7/12/2013||Stefano Pessina||Director||Buy||34,439||$45.77||$1,576,273.03|| |
|5/21/2013||Kermit R Crawford||Insider||Sell||10,000||$50.03||$500,300.00|| |
|4/19/2013||Stefano Pessina||Director||Buy||83,299||$48.62||$4,049,997.38|| |
Headline Trends for Walgreens Boots Alliance (NASDAQ:WBA)
Latest Headlines for Walgreens Boots Alliance (NASDAQ:WBA)
Loading headlines, please wait.
Walgreens Boots Alliance (WBA) Chart for Sunday, October, 22, 2017